DCI Azalea Place is a medicare approved dialysis facility center in Charleston, South Carolina and it has 20 dialysis stations. It is located in Charleston county at 2270 Technical Parkway, Charleston, SC, 29406. You can reach out to the office of DCI Azalea Place at (843) 863-8974. This dialysis clinic is managed and/or owned by Dialysis Clinic, Inc.. DCI Azalea Place has the following ownership type - Non-Profit. It was first certified by medicare in July, 1986. The medicare id for this facility is 422524 and it accepts patients under medicare ESRD program.
| Name | DCI Azalea Place |
|---|---|
| Location | 2270 Technical Parkway, Charleston, South Carolina |
| No. of Dialysis Stations | 20 |
| Medicare ID | 422524 |
| Managed By | Dialysis Clinic, Inc. |
| Ownership Type | Non-Profit |
| Late Shifts | No |
| 2270 Technical Parkway, Charleston, South Carolina, 29406 | |
| (843) 863-8974 | |
News Archive
Agfa HealthCare announces today that it will launch its new mobile DR system with FreeView telescopic column at AHRA 2015, the Association for Medical Imaging Management's annual meeting, in Las Vegas, Nevada, July 19-22.
Immune cells ensnare dangerous cells that are on the run with a bungee-like nanotube, according to research published today in the Proceedings of the National Academy of Sciences. The study, by researchers from Imperial College London, shows that natural killer (NK) cells use this bungee to destroy cells that could otherwise escape them.
A.P. Pharma, Inc., a specialty pharmaceutical company, today announced it has received the final milestone payment of $2.5 million from an affiliate of Paul Capital Healthcare.
Lantheus Medical Imaging, Inc. today announced that it intends to offer $150 million in aggregate principal amount of its 9.750% Senior Notes due 2017 (the "New Notes"). The New Notes are being offered as additional debt securities under an indenture pursuant to which Lantheus previously issued $250 million in aggregate principal amount of 9.750% Senior Notes due 2017.
Beauty goes the old saying, "is in the eye of the beholder." But does the beholder have to be human?
› Verified 6 days ago
| NPI Number | 1578596953 |
| Doing Business As | Dialysis Clinic Inc. |
| Address | 2270 Technical Pkwy Charleston, South Carolina, 29406 |
| Phone Number | (843) 723-7227 |
News Archive
Agfa HealthCare announces today that it will launch its new mobile DR system with FreeView telescopic column at AHRA 2015, the Association for Medical Imaging Management's annual meeting, in Las Vegas, Nevada, July 19-22.
Immune cells ensnare dangerous cells that are on the run with a bungee-like nanotube, according to research published today in the Proceedings of the National Academy of Sciences. The study, by researchers from Imperial College London, shows that natural killer (NK) cells use this bungee to destroy cells that could otherwise escape them.
A.P. Pharma, Inc., a specialty pharmaceutical company, today announced it has received the final milestone payment of $2.5 million from an affiliate of Paul Capital Healthcare.
Lantheus Medical Imaging, Inc. today announced that it intends to offer $150 million in aggregate principal amount of its 9.750% Senior Notes due 2017 (the "New Notes"). The New Notes are being offered as additional debt securities under an indenture pursuant to which Lantheus previously issued $250 million in aggregate principal amount of 9.750% Senior Notes due 2017.
Beauty goes the old saying, "is in the eye of the beholder." But does the beholder have to be human?
› Verified 6 days ago
| Dialysis patients with Hemoglobin data | 34 |
| Medicare patients who had average hemoglobin (hgb) less than 10 g/dL | 29 |
News Archive
Agfa HealthCare announces today that it will launch its new mobile DR system with FreeView telescopic column at AHRA 2015, the Association for Medical Imaging Management's annual meeting, in Las Vegas, Nevada, July 19-22.
Immune cells ensnare dangerous cells that are on the run with a bungee-like nanotube, according to research published today in the Proceedings of the National Academy of Sciences. The study, by researchers from Imperial College London, shows that natural killer (NK) cells use this bungee to destroy cells that could otherwise escape them.
A.P. Pharma, Inc., a specialty pharmaceutical company, today announced it has received the final milestone payment of $2.5 million from an affiliate of Paul Capital Healthcare.
Lantheus Medical Imaging, Inc. today announced that it intends to offer $150 million in aggregate principal amount of its 9.750% Senior Notes due 2017 (the "New Notes"). The New Notes are being offered as additional debt securities under an indenture pursuant to which Lantheus previously issued $250 million in aggregate principal amount of 9.750% Senior Notes due 2017.
Beauty goes the old saying, "is in the eye of the beholder." But does the beholder have to be human?
› Verified 6 days ago
Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.
| Adult patients getting regular hemodialysis at the center | 56 |
| Adult patient months included in Kt/V greater than or equal to 1.2 | 547 |
| Percentage of adult patients getting regular hemodialysis at the center | 89 |
News Archive
Agfa HealthCare announces today that it will launch its new mobile DR system with FreeView telescopic column at AHRA 2015, the Association for Medical Imaging Management's annual meeting, in Las Vegas, Nevada, July 19-22.
Immune cells ensnare dangerous cells that are on the run with a bungee-like nanotube, according to research published today in the Proceedings of the National Academy of Sciences. The study, by researchers from Imperial College London, shows that natural killer (NK) cells use this bungee to destroy cells that could otherwise escape them.
A.P. Pharma, Inc., a specialty pharmaceutical company, today announced it has received the final milestone payment of $2.5 million from an affiliate of Paul Capital Healthcare.
Lantheus Medical Imaging, Inc. today announced that it intends to offer $150 million in aggregate principal amount of its 9.750% Senior Notes due 2017 (the "New Notes"). The New Notes are being offered as additional debt securities under an indenture pursuant to which Lantheus previously issued $250 million in aggregate principal amount of 9.750% Senior Notes due 2017.
Beauty goes the old saying, "is in the eye of the beholder." But does the beholder have to be human?
› Verified 6 days ago
An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at DCI Azalea Place with elevated calcium levels.
| Patients with hypercalcemia | 57 |
| Hypercalcemia patient months | 560 |
| Hypercalcemia patients with serumcalcium greater than 10.2 mg | 1 |
| Patients with Serumphosphor | 58 |
| Patients with Serumphosphor less than 3.5 mg/dL | 10 |
| Patients with Serumphosphor from 3.5 to 4.5 mg/dL | 24 |
| Patients with Serumphosphor from 4.6 to 5.5 mg/dL | 25 |
| Patients with Serumphosphor from 5.6 to 7 mg/dL | 30 |
| Patients with Serumphosphor greater than 7 mg/dL | 11 |
News Archive
Agfa HealthCare announces today that it will launch its new mobile DR system with FreeView telescopic column at AHRA 2015, the Association for Medical Imaging Management's annual meeting, in Las Vegas, Nevada, July 19-22.
Immune cells ensnare dangerous cells that are on the run with a bungee-like nanotube, according to research published today in the Proceedings of the National Academy of Sciences. The study, by researchers from Imperial College London, shows that natural killer (NK) cells use this bungee to destroy cells that could otherwise escape them.
A.P. Pharma, Inc., a specialty pharmaceutical company, today announced it has received the final milestone payment of $2.5 million from an affiliate of Paul Capital Healthcare.
Lantheus Medical Imaging, Inc. today announced that it intends to offer $150 million in aggregate principal amount of its 9.750% Senior Notes due 2017 (the "New Notes"). The New Notes are being offered as additional debt securities under an indenture pursuant to which Lantheus previously issued $250 million in aggregate principal amount of 9.750% Senior Notes due 2017.
Beauty goes the old saying, "is in the eye of the beholder." But does the beholder have to be human?
› Verified 6 days ago
The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.
| Patients included in arterial venous fistula and catheter summaries | 65 |
| Patient months included in arterial venous fistula and catheter summaries | 457 |
| Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment | 57 |
| Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer | 13 |
News Archive
Agfa HealthCare announces today that it will launch its new mobile DR system with FreeView telescopic column at AHRA 2015, the Association for Medical Imaging Management's annual meeting, in Las Vegas, Nevada, July 19-22.
Immune cells ensnare dangerous cells that are on the run with a bungee-like nanotube, according to research published today in the Proceedings of the National Academy of Sciences. The study, by researchers from Imperial College London, shows that natural killer (NK) cells use this bungee to destroy cells that could otherwise escape them.
A.P. Pharma, Inc., a specialty pharmaceutical company, today announced it has received the final milestone payment of $2.5 million from an affiliate of Paul Capital Healthcare.
Lantheus Medical Imaging, Inc. today announced that it intends to offer $150 million in aggregate principal amount of its 9.750% Senior Notes due 2017 (the "New Notes"). The New Notes are being offered as additional debt securities under an indenture pursuant to which Lantheus previously issued $250 million in aggregate principal amount of 9.750% Senior Notes due 2017.
Beauty goes the old saying, "is in the eye of the beholder." But does the beholder have to be human?
› Verified 6 days ago
The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.
| Standard Hospitalization Summary Ratio(SHR) Year | January, 2016 - December, 2016 |
| Patients in facility's Hospitalization Summary | 55 |
| Hospitalization Rate in facility | 317.2 (Worse than Expected) |
| Hospitalization Rate: Upper Confidence Limit | 483.6 |
| Hospitalization Rate: Lower Confidence Limit | 214.3 |
News Archive
Agfa HealthCare announces today that it will launch its new mobile DR system with FreeView telescopic column at AHRA 2015, the Association for Medical Imaging Management's annual meeting, in Las Vegas, Nevada, July 19-22.
Immune cells ensnare dangerous cells that are on the run with a bungee-like nanotube, according to research published today in the Proceedings of the National Academy of Sciences. The study, by researchers from Imperial College London, shows that natural killer (NK) cells use this bungee to destroy cells that could otherwise escape them.
A.P. Pharma, Inc., a specialty pharmaceutical company, today announced it has received the final milestone payment of $2.5 million from an affiliate of Paul Capital Healthcare.
Lantheus Medical Imaging, Inc. today announced that it intends to offer $150 million in aggregate principal amount of its 9.750% Senior Notes due 2017 (the "New Notes"). The New Notes are being offered as additional debt securities under an indenture pursuant to which Lantheus previously issued $250 million in aggregate principal amount of 9.750% Senior Notes due 2017.
Beauty goes the old saying, "is in the eye of the beholder." But does the beholder have to be human?
› Verified 6 days ago
The rate of readmission show you whether patients who were being treated regularly at DCI Azalea Place were readmitted more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other dialysis centers.
| Standard Readmission Summary Ratio(SRR) Year | January, 2016 - December, 2016 |
| Readmission Rate in facility | 37.9 (As Expected) |
| Readmission Rate: Upper Confidence Limit | 50.8 |
| Readmission Rate: Lower Confidence Limit | 26 |
News Archive
Agfa HealthCare announces today that it will launch its new mobile DR system with FreeView telescopic column at AHRA 2015, the Association for Medical Imaging Management's annual meeting, in Las Vegas, Nevada, July 19-22.
Immune cells ensnare dangerous cells that are on the run with a bungee-like nanotube, according to research published today in the Proceedings of the National Academy of Sciences. The study, by researchers from Imperial College London, shows that natural killer (NK) cells use this bungee to destroy cells that could otherwise escape them.
A.P. Pharma, Inc., a specialty pharmaceutical company, today announced it has received the final milestone payment of $2.5 million from an affiliate of Paul Capital Healthcare.
Lantheus Medical Imaging, Inc. today announced that it intends to offer $150 million in aggregate principal amount of its 9.750% Senior Notes due 2017 (the "New Notes"). The New Notes are being offered as additional debt securities under an indenture pursuant to which Lantheus previously issued $250 million in aggregate principal amount of 9.750% Senior Notes due 2017.
Beauty goes the old saying, "is in the eye of the beholder." But does the beholder have to be human?
› Verified 6 days ago
Hemodialysis treatment requires direct access to the bloodstream, which can be an opportunity for germs to enter the body and cause infection. This information shows how often patients at DCI Azalea Place get infections in their blood each year compared to the number of infections expected for the center based on the national average.
| Standard Infection Summary Ratio(SIR) Year | January, 2016 - December, 2016 |
| Infection Rate in facility | .28 (As Expected) |
| SIR: Upper Confidence Limit | 1.4 |
| SIR: Lower Confidence Limit | .01 |
News Archive
Agfa HealthCare announces today that it will launch its new mobile DR system with FreeView telescopic column at AHRA 2015, the Association for Medical Imaging Management's annual meeting, in Las Vegas, Nevada, July 19-22.
Immune cells ensnare dangerous cells that are on the run with a bungee-like nanotube, according to research published today in the Proceedings of the National Academy of Sciences. The study, by researchers from Imperial College London, shows that natural killer (NK) cells use this bungee to destroy cells that could otherwise escape them.
A.P. Pharma, Inc., a specialty pharmaceutical company, today announced it has received the final milestone payment of $2.5 million from an affiliate of Paul Capital Healthcare.
Lantheus Medical Imaging, Inc. today announced that it intends to offer $150 million in aggregate principal amount of its 9.750% Senior Notes due 2017 (the "New Notes"). The New Notes are being offered as additional debt securities under an indenture pursuant to which Lantheus previously issued $250 million in aggregate principal amount of 9.750% Senior Notes due 2017.
Beauty goes the old saying, "is in the eye of the beholder." But does the beholder have to be human?
› Verified 6 days ago
Patients with anemia require blood transfusions if their anemia is not managed well by their dialysis center. This information shows whether DCI Azalea Place's rate of transfusions is better than expected, as expected, or worse than expected, compared to other centers that treat similar patients.
| Standard Transfusion Summary Ratio (STrR) Year | January, 2016 - December, 2016 |
| Patients in facility's Transfusion Summary | 45 |
| Transfusion Rate in facility | 89.3 (Worse than Expected) |
| Transfusion Rate: Upper Confidence Limit | 183.7 |
| Transfusion Rate: Lower Confidence Limit | 47.4 |
News Archive
Agfa HealthCare announces today that it will launch its new mobile DR system with FreeView telescopic column at AHRA 2015, the Association for Medical Imaging Management's annual meeting, in Las Vegas, Nevada, July 19-22.
Immune cells ensnare dangerous cells that are on the run with a bungee-like nanotube, according to research published today in the Proceedings of the National Academy of Sciences. The study, by researchers from Imperial College London, shows that natural killer (NK) cells use this bungee to destroy cells that could otherwise escape them.
A.P. Pharma, Inc., a specialty pharmaceutical company, today announced it has received the final milestone payment of $2.5 million from an affiliate of Paul Capital Healthcare.
Lantheus Medical Imaging, Inc. today announced that it intends to offer $150 million in aggregate principal amount of its 9.750% Senior Notes due 2017 (the "New Notes"). The New Notes are being offered as additional debt securities under an indenture pursuant to which Lantheus previously issued $250 million in aggregate principal amount of 9.750% Senior Notes due 2017.
Beauty goes the old saying, "is in the eye of the beholder." But does the beholder have to be human?
› Verified 6 days ago
The rate of mortality show you whether patients who were being treated regularly at DCI Azalea Place lived longer than expected (better than expected), don’t live as long as expected (worse than expected), or lived as long as expected (as expected), compared to similar patients treated at other facilities.
| Standard Survival Summary Ratio(SIR) Year | January, 2013 - December, 2016 |
| Patients in facility's Survival Summary | 269 |
| Mortality Rate in facility | 23.7 (As Expected) |
| Mortality Rate: Upper Confidence Limit | 32.8 |
| Mortality Rate: Lower Confidence Limit | 16.6 |
News Archive
Agfa HealthCare announces today that it will launch its new mobile DR system with FreeView telescopic column at AHRA 2015, the Association for Medical Imaging Management's annual meeting, in Las Vegas, Nevada, July 19-22.
Immune cells ensnare dangerous cells that are on the run with a bungee-like nanotube, according to research published today in the Proceedings of the National Academy of Sciences. The study, by researchers from Imperial College London, shows that natural killer (NK) cells use this bungee to destroy cells that could otherwise escape them.
A.P. Pharma, Inc., a specialty pharmaceutical company, today announced it has received the final milestone payment of $2.5 million from an affiliate of Paul Capital Healthcare.
Lantheus Medical Imaging, Inc. today announced that it intends to offer $150 million in aggregate principal amount of its 9.750% Senior Notes due 2017 (the "New Notes"). The New Notes are being offered as additional debt securities under an indenture pursuant to which Lantheus previously issued $250 million in aggregate principal amount of 9.750% Senior Notes due 2017.
Beauty goes the old saying, "is in the eye of the beholder." But does the beholder have to be human?
› Verified 6 days ago
DCI West Ashley Location: 46 B Markfield Road, Charleston, South Carolina, 29407 Phone: (843) 766-2317 |
DCI Azalea Place Location: 2270 Technical Parkway, Charleston, South Carolina, 29406 Phone: (843) 863-8974 |
DCI Magnolia Court Location: 1427 King Street, Charleston, South Carolina, 29403 Phone: (843) 853-3399 |
RAI Care Centers Charleston Location: 2080 Charlie Hall Blvd, Charleston, South Carolina, 29414 Phone: (843) 766-4655 |
News Archive
Agfa HealthCare announces today that it will launch its new mobile DR system with FreeView telescopic column at AHRA 2015, the Association for Medical Imaging Management's annual meeting, in Las Vegas, Nevada, July 19-22.
Immune cells ensnare dangerous cells that are on the run with a bungee-like nanotube, according to research published today in the Proceedings of the National Academy of Sciences. The study, by researchers from Imperial College London, shows that natural killer (NK) cells use this bungee to destroy cells that could otherwise escape them.
A.P. Pharma, Inc., a specialty pharmaceutical company, today announced it has received the final milestone payment of $2.5 million from an affiliate of Paul Capital Healthcare.
Lantheus Medical Imaging, Inc. today announced that it intends to offer $150 million in aggregate principal amount of its 9.750% Senior Notes due 2017 (the "New Notes"). The New Notes are being offered as additional debt securities under an indenture pursuant to which Lantheus previously issued $250 million in aggregate principal amount of 9.750% Senior Notes due 2017.
Beauty goes the old saying, "is in the eye of the beholder." But does the beholder have to be human?
› Verified 6 days ago